semaglutide poisoning approval boosts GLP-1 poison center reports Semaglutide Linked to Spike in

Are employers ready for that trend to continue

In this narrative review we summarize the evidence on the safety of liraglutide, semaglutide, and tirzepatide as derived from randomized clinical trials conducted in adults living with obesity

Recent Findings Newer generation GLP-1 based therapies have become more effective for the treatment of overweight and obesity, with data supporting tirzepatide as the most effective, followed by semaglutide and then liraglutide

Linhda Nguyen, PA-C, a physician assistant at the Healthy Weight and Wellness Clinic at Nemours Childrens Health in Wilmington, Delaware, said GLP-1 prescriptions for adolescents have increased since the approval of